ClinicalTrials.gg
CompletedNCT05028413Updated Oct 1, 2024Results posted

Evaluating Perceived Fitness to Drive While Intoxicated

An interventional study of Participants Shown their Breath Alcohol Content Measurement in Alcohol Drinking, Alcohol Intoxication and Perception, Self, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to participants aged 21 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-01.

Primary conditionAlcohol Drinking(the registry's first term)UnverifiedIs this wrong?Alcohol Drinking is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 years 3 months after the study started (first participant enrolled May 2017, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
21 Years to 39 Years
Sex
All
01

Study summary

The goal of this study is to conduct a laboratory-based pilot randomized control trial of smartphone-enabled breath alcohol monitoring on perceived fitness to drive a vehicle among intoxicated adults. The study team will enroll up to 30 adults aged > 21-44 who are frequent drinkers without dependence who drive more than four times per week to complete a standardized alcohol drinking protocol in a monitored setting collecting breathalyzer measurements. The protocol involves consuming three weight-based doses of alcohol with a target BAC of 0.10 and completing breathalyzer measurements every 20 minutes until a BAC of 0.03 is reached. The control group will complete a visual analog scale on their perceived fitness to drive and be blinded to their breath alcohol readings with the BACtrack Mobile Pro breathalyzer device, while the intervention group would do the same, but be shown their breath alcohol readings on the paired BACtrack smartphone application. The research team's previous research has validated the accuracy of the BACtrack Mobile Pro device to measure BAC within +/- 0.001 of police-grade breathalyzer and estimate BAC within +/- 0.01 of a blood test.

02

Conditions studied

  • Alcohol Drinking
  • Alcohol Intoxication
  • Perception, Self
  • Drinking, Alcohol
  • Driving Under the Influence
  • Drinking Behavior
03

In context

Alcohol Drinking Unverified

701 studies on the registry are indexed under Alcohol Drinking; 133 are open to participants now.

This study's enrollment of 22 is below the median of 122 across 607 interventional studies indexed under Alcohol Drinking.

Browse Alcohol Drinking studies →

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,668 studies on the registry; 235 are open to participants now.

Of its 158 completed or terminated interventional studies of FDA-regulated products, 109 (69%) have results posted.

Compared within Alcohol Drinking, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
21 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 21-39 years old,
  • Less than 4 drinking days and less than 12 drinks per week on average in the past 2 months,
  • Have consumed at least 4 (women) or 5 (men) drinks on one occasion, in the past year without experiencing adverse effects
  • Have a valid photo ID
  • Willing and able to use a rideshare credit or septa token as transportation home from the study visit
  • Drives at least 2 days per week on average.

Exclusion criteria

Exclusion Criteria:

  • Desire alcohol treatment now or received it in the past 6 months,
  • Have Alcohol use disorder per criteria
  • Meet or have met criteria for a substance use disorder within the past 12 months per DSM V criteria
  • Have a prior psychiatric condition requiring hospitalization
  • Are non-English-speaking
  • Individuals who have a medical condition or who are taking medication which limits or prevents the consumption of alcohol
  • Are experiencing suicidal ideation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • No intervention
    Participants Blinded to BrAC reading (Control)

    Participants randomized to this arm will consume three weight-based doses of alcohol with a target BAC of 0.10 and comple breathalyzer measurements every 20 minutes until a BAC of 0.03 is reached. They will complete a visual analog scale (the Self-Reported intoxication Survey) on their perceived fitness to drive and be blinded to their breath alcohol readings with the BACtrack Mobile Pro device.

  • Experimental
    Participants Aware of their BrAC reading

    Participants randomized to this arm will consume three weight-based doses of alcohol with a target BAC of 0.10 and comple breathalyzer measurements every 20 minutes until a BAC of 0.03 is reached. They will be shown their breath alcohol readings with the BACtrack Mobile Pro device before completing a visual analog scale (the Self-Reported intoxication Survey) on their perceived fitness to drive.

    Behavioral: Participants Shown their Breath Alcohol Content Measurement

Interventions

  • BehavioralParticipants Shown their Breath Alcohol Content Measurement

    Each time a Breath Alcohol Content (BrAC) Measurement is taken by the research team, the participant is shown the measurement before completing the paper visual analog scale scale (the Self-Reported intoxication Survey) on their perceived fitness to drive.

06

What researchers measure

Primary outcomes

  1. Participants' Perceived Fitness to Drive Measurement

    Participant's self rating on visual analog scale from 1-10 (1: Extremely Able to Drive; 10: Not at all Able to Drive) after Breath Alcohol Content Measurement was collected

    Time frame: The duration of study visit, up to 8 hours

Secondary outcomes

  1. Participants' Perceived Willingness to Drive Measurement

    Participant's self rating on visual analog scale from 1-10 (1: Not at all Willing to Drive; 10: Extremely Willing to Drive) after Breath Alcohol Content Measurement was collected

    Time frame: The duration of study visit, up to 8 hours

07

Results

Posted Oct 1, 2024

Participant flow

Participant flow — Overall Study
MilestoneParticipants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC Reading
Started1010
Completed1010
Not completed00

Outcome measures

PrimaryParticipants' Perceived Fitness to Drive Measurement

Participant's self rating on visual analog scale from 1-10 (1: Extremely Able to Drive; 10: Not at all Able to Drive) after Breath Alcohol Content Measurement was collected

Time frame:
The duration of study visit, up to 8 hours
Reported as:
Mean · units on a scale
Participants' Perceived Fitness to Drive Measurement
units on a scaleParticipants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC Reading
Participants' Perceived Fitness to Drive Measurement6.5 ± 2.54.6 ± 1.9
SecondaryParticipants' Perceived Willingness to Drive Measurement

Participant's self rating on visual analog scale from 1-10 (1: Not at all Willing to Drive; 10: Extremely Willing to Drive) after Breath Alcohol Content Measurement was collected

Time frame:
The duration of study visit, up to 8 hours
Reported as:
Mean · units on a scale
Participants' Perceived Willingness to Drive Measurement
units on a scaleParticipants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC Reading
Participants' Perceived Willingness to Drive Measurement3.5 ± 2.35.5 ± 2.5

Adverse events

Collected over 8 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Participants Blinded to BrAC Reading (Control)0/10 (0%)0/10 (0%)0/10 (0%)
Participants Aware of Their BrAC Reading0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

20 patients analyzed between the ages of 21 and 39 that have a driver's license and have consumed alcohol (4 or more drinks for a woman)/ ( or more drinks or men) in on driving occasion without any problems. Participants have not received alcohol treatment in the last 6 months, do not desire alcohol treatment, nor are pregnant or nursing.

Age, Categorical
Age, Categorical(Participants)Participants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC ReadingTotal
<=18 years000
Between 18 and 65 years101020
>=65 years000
Age, Continuous
Age, Continuous(years)Participants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC ReadingTotal
Mean25.7 ± 4.228.5 ± 4.227.1 ± 4.6
Sex: Female, Male
Sex: Female, Male(Participants)Participants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC ReadingTotal
Female358
Male7512
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Participants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC ReadingTotal
Hispanic or Latino000
Not Hispanic or Latino101020
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Participants Blinded to BrAC Reading (Control)Participants Aware of Their BrAC ReadingTotal
United States — White7916
United States — Asian303
United States — Black011
08

Study locations

1 site
  • Perelman Center for Advanced Medicine
    Philadelphia, Pennsylvania 19104, United States
09

References and documents

Publications

  • Harrison EL, Marczinski CA, Fillmore MT. Driver training conditions affect sensitivity to the impairing effects of alcohol on a simulated driving test [corrected]. Exp Clin Psychopharmacol. 2007 Dec;15(6):588-98. doi: 10.1037/1064-1297.15.6.588. Erratum In: Exp Clin Psychopharmacol. 2008 Apr;16(2):177. PubMed 18179312 ↗
  • Harrison EL, Fillmore MT. Are bad drivers more impaired by alcohol? Sober driving precision predicts impairment from alcohol in a simulated driving task. Accid Anal Prev. 2005 Sep;37(5):882-9. doi: 10.1016/j.aap.2005.04.005. PubMed 15907777 ↗
  • Marczinski CA, Stamates AL. Artificial sweeteners versus regular mixers increase breath alcohol concentrations in male and female social drinkers. Alcohol Clin Exp Res. 2013 Apr;37(4):696-702. doi: 10.1111/acer.12039. Epub 2012 Dec 6. PubMed 23216417 ↗
  • McCarthy DM, Niculete ME, Treloar HR, Morris DH, Bartholow BD. Acute alcohol effects on impulsivity: associations with drinking and driving behavior. Addiction. 2012 Dec;107(12):2109-14. doi: 10.1111/j.1360-0443.2012.03974.x. Epub 2012 Aug 10. PubMed 22690907 ↗
  • Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995 Nov;51(6):768-74. doi: 10.1002/1097-4679(199511)51:63.0.co;2-1. PubMed 8778124 ↗
  • Senecal N, Wang T, Thompson E, Kable JW. Normative arguments from experts and peers reduce delay discounting. Judgm Decis Mak. 2012 Sep 1;7(5):568-589. PubMed 23596504 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05028413
Responsible party
M. Kit Delgado, MD (Assistant Professor of Emergency Medicine and Epidemiology, University of Pennsylvania) — Principal investigator
First posted
Aug 31, 2021
Start date
May 8, 2017
Primary completion
Jun 23, 2017
Completion
Jun 23, 2017
Results posted
Oct 1, 2024
Last update
Oct 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion